Study on the correlation between CD112R and CD96 and ankylosing spondylitis

Case-control study: the relationship between CD112R and CD96 and ankylosing spondylitis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100042212

Enrollment

Unknown

Registered

2021-01-15

Start date

2021-01-20

Completion date

Unknown

Last updated

2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankylosing spondylitis

Interventions

case group:Nil

healthy control group:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients definitely diagnosed as ankylosing spondylitis.

Exclusion criteria

Exclusion criteria: Patients with immunosuppressive therapy recently.

Design outcomes

Primary

Measure	Time frame
CD112R;CD96;	—

Countries

China

Contacts

Public ContactFengqing Wu

Zhejiang Chinese Medical University

1015350429@qq.com+86 18067970997

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026